PharmaBoardroom

Vincent Gruntz – General Manager Oncology, Novartis Pharma…

Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious approach is being taken to reimbursement…

Can Europe’s Beating Cancer Plan Make it an Innovation…

The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in Europe, and its potential to boost the…

Kevin Zou – Head of Oncology Asia Pacific & Country…

Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the challenges of introducing cutting-edge…

Bertrand Ducrey – CEO, Debiopharm

In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug improvement, drug delivery, and drug…

Alessandro Riva – CEO, Ichnos Sciences

Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in oncology R&D at Novartis and…

HiFiBiO CEO on the Keys to Global Biotech Success

HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T: advanced degrees in different…

Liang Schweizer – CEO & CSO, HiFiBiO Therapeutics

Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the company’s unique single-cell technology…

Chris Martin – CEO, Co-Founder and Director, ADC…

Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC Therapeutics, shares the company’s journey…

Stefan Hendriks – Global Head Cell & Gene, Novartis…

Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression to becoming the global leader in…

Ipsen CEO David Loew on M&A, Rare Disease Expansion, Niche…

In a wide-ranging and exclusive interview with PharmaBoardroom, Ipsen CEO David Loew looks back on an atypical first 100 days at the helm of the…

Photocure: Swimming in the “Blue Ocean” of Oncology…

Photodynamic therapy (PDT) firm Photocure is probably Norway’s most significant recent international healthcare success story. CEO Dan Schneider…

Japan’s Taiho Pharmaceutical: An Oral Chemotherapy Pioneer

Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known player may be Taiho…

Tagged with Oncology